From my experience in other biotech stocks, the FDA approval can...

From my experience in other biotech stocks, the FDA approval can be a back and forth process that takes time for a device that claims health benefits. And usually there are numerous trials to provide data for approval. Is PO3 able to just adapt their tech to whatever device they choose and bring it to market? Or will it have to go through the normal hoops? If its the latter i think they should still announce any intention to get into the air purification market as it will excite the market - albeit for a brief time - but it would set the platform for next year's pandemic scare.